AVNS Q3 2020 Earnings — Avanos Medical, Inc. Revenue & Financial Results | Market Cap Arena

AVNSAvanos Medical, Inc.

$610M

Q3 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$186M+8.3% YoY

Gross Profit

$100M53.7% margin

Operating Income

$16M8.7% margin

Net Income

$19M10.4% margin

EPS (Diluted)

$0.40

QoQ Revenue Growth

+13.4%

Cash Flow

Operating Cash Flow

$1M

Free Cash Flow

-$2M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$1.8B

Total Liabilities

$509M

Stockholders' Equity

$1.3B

Cash & Equivalents

$180M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$186M	$171M	+8.3%
Gross Profit	$100M	$95M	+4.9%
Operating Income	$16M	$5M	+242.6%
Net Income	$19M	-$12M	+267.8%

Revenue Segments

Chronic Care

$119M64%

Pain Management

$66M36%